Cormorant Asset Management, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.43 Billion distributed in 45 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $428M, Vaxcyte, Inc. with a value of $114M, Arcellx, Inc. with a value of $104M, Longboard Pharmaceuticals, Inc. with a value of $93M, and Edgewise Therapeutics, Inc. with a value of $90.9M.
Examining the 13F form we can see an increase of $128M in the current position value, from $1.3B to 1.43B.
Cormorant Asset Management, LP is based out at Boston, MA
Below you can find more details about Cormorant Asset Management, LP portfolio as well as his latest detailed transactions.
